Greyson International Inc. to Hold Investor Conference Call on Thursday, November 21, 2013

Greyson International Inc. to Hold Investor Conference Call on Thursday, November 21, 2013

Coconut Creek, Fla. – November 19, 2013 – Greyson International, Inc. (OTC Pink Sheets: GYSN), developer of an innovative-patented topical delivery technology targeting the multi-billion dollar cosmetics and OTC pharmaceutical industries, today announced that it would be holding an investor conference call on Thursday, November 21, 2013, at 4:15 pm EDT. The conference call dial in number is 530-881-1300 and the Participant Access Code is 934487. The recorded version of the conference call will be available for playback after the call is concluded. Dial 530-881-1399 to listen.

“Our company has laid the foundation and set into motion the launch of Greyson Skincare, licensing deals and pharmaceutical joint ventures. I’m looking forward to giving details on these activities,” said Harvey Tauman, CEO of Greyson International Inc. “In addition, I’m looking forward to discussing our future plans on this call, as we bring our patented Trilexon trans-dermal delivery system to market and ultimately unlock significant value for our shareholders in 2014 and beyond.”

In preparation you may view the new videos on the Greyson website.

Welcome (Company & Technology Overview)

Detailed explanation of Trilexon® technology (second video)

Live Financial Investor Presentation Oct. 2013


About Greyson International, Inc.

Greyson’s primary focus is on its recently patented Trilexon® delivery system that’s taking the multi-billion dollar cosmetics and OTC pharmaceuticals industries by storm. Based on this technology, the company’s patented Trilexon® foundation creates a fine surface that is insoluble in water, keeping it in place even after sweating or contact with water. Ingredients are released continuously over an extended period of time, ensuring that the skin receives treatment at a constant steady pace to give it a healthy and youthful look. In addition to cosmetic applications, Trilexon® has benefits in the medical field where it is important to deliver topical active ingredients. Trilexon® is a registered trademark of Greyson International. The company also holds an investment in Blake Oil and Gas Limited (“Blake”), a privately owned, Guernsey registered, Oil and Gas Company. For more information, visit our website; http://greysonintl.comand join the Greyson International’s Facebook page

This release contains information about management’s view of our future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with our financial condition, our ability to sell our products and our ability to compete with competitors. We encourage you to review other factors that may affect our future results on any current or future documents we file periodically with the Securities & Exchange Commission.


Harvey Tauman

Greyson International Inc.

Chief Executive Officer

(954) 482-0497

Recommended Posts